A genetic journey through cancer: from rarity and family to aspirin and nanowires by Burn J

Get full text

Bowel cancer chemoprevention - ready for the clinic? by Burn J

Get full text

Acknowledgment to the Reviewers of <i>Eur. Burn J.</i> in 2022 by Eur. Burn J. Editorial Office

Get full text

The non-deletion type of alpha thalassaemia/mental retardation: a recognisable dysmorphic syndrome with X linked inheritance. by Wilkie, A, Pembrey, M, Gibbons, R, Higgs, D, Porteous, M, Burn, J, Winter, R

PPM-X: a new X-linked mental retardation syndrome with psychosis, pyramidal signs, and macroorchidism maps to Xq28. by Lindsay, S, Splitt, M, Edney, S, Berney, T, Knight, S, Davies, K, O'Brien, O, Gale, M, Burn, J

Isolation of a new marker and conserved sequences close to the DiGeorge syndrome marker HP500 (D22S134). by Wadey, R, Daw, S, Wickremasinghe, A, Roberts, C, Wilson, D, Goodship, J, Burn, J, Halford, S, Scambler, P

Aspirin, salicylates and cancer by Morgan, G, Rothwell, P, Burn, J, Chan, A, Mur, L, Morton, D, Cuzick, J, McVie, G

Brief report: autosomal dominant familial hypoparathyroidism, sensorineural deafness, and renal dysplasia. by Bilous, R, Murty, G, Parkinson, D, Thakker, R, Coulthard, MG, Burn, J, Mathias, D, Kendall-Taylor, P

Isolation of a gene expressed during early embryogenesis from the region of 22q11 commonly deleted in DiGeorge syndrome. by Halford, S, Wilson, D, Daw, S, Roberts, C, Wadey, R, Kamath, S, Wickremasinghe, A, Burn, J, Goodship, J, Mattei, MG

Molecular genetic study of the frequency of monosomy 22q11 in DiGeorge syndrome. by Carey, A, Kelly, D, Halford, S, Wadey, R, Wilson, D, Goodship, J, Burn, J, Paul, T, Sharkey, A, Dumanski, J

Isolation of a gene encoding an integral membrane protein from the vicinity of a balanced translocation breakpoint associated with DiGeorge syndrome. by Wadey, R, Daw, S, Taylor, C, Atif, U, Kamath, S, Halford, S, O'Donnell, H, Wilson, D, Goodship, J, Burn, J

Clinical and hematologic aspects of the X-linked alpha-thalassemia/mental retardation syndrome (ATR-X). by Gibbons, R, Brueton, L, Buckle, V, Burn, J, Clayton-Smith, J, Davison, B, Gardner, R, Homfray, T, Kearney, L, Kingston, H

Aspirin in the chemoprevention of colorectal neoplasia: an overview. by Chan, A, Arber, N, Burn, J, Chia, W, Elwood, P, Hull, M, Logan, R, Rothwell, P, Schrör, K, Baron, J

Aspirin and non-steroidal anti-inflammatory drugs for cancer prevention: an international consensus statement. by Cuzick, J, Otto, F, Baron, J, Brown, P, Burn, J, Greenwald, P, Jankowski, J, La Vecchia, C, Meyskens, F, Senn, H, Thun, M

MOLECULAR STUDIES OF MONOSOMY-22Q11 AND ITS CLINICAL CONSEQUENCES by Scambler, P, Halford, S, Wadey, R, Lindsay, E, Kelly, D, Wilson, D, Goodship, J, Burn, J, Goldberg, R, Shprintzen, R, Williamson, R, Carey, A

Mutations in RNF135, a gene within the NF1 microdeletion region, cause phenotypic abnormalities including overgrowth. by Douglas, J, Cilliers, D, Coleman, K, Tatton-Brown, K, Barker, K, Bernhard, B, Burn, J, Huson, S, Josifova, D, Lacombe, D, Malik, M, Mansour, S, Reid, E, Cormier-Daire, V, Cole, T, Rahman, N

CATCH-22 - CAN MOLECULAR GENETICS EXPLAIN THE PHENOTYPE by Halford, S, Wadey, R, Roberts, C, Daw, S, Whiting, J, Odonnell, H, Dunham, I, Bentley, D, Lindsay, E, Baldini, A, Francis, F, Lehrach, H, Williamson, R, Wilson, D, Goodship, J, Cross, I, Burn, J, Scambler, P

MLH1 germline epimutations as a factor in hereditary nonpolyposis colorectal cancer. by Hitchins, M, Williams, R, Cheong, K, Halani, N, Lin, V, Packham, D, Ku, S, Buckle, A, Hawkins, N, Burn, J, Gallinger, S, Goldblatt, J, Kirk, J, Tomlinson, I, Scott, R, Spigelman, A, Suter, C, Martin, D, Suthers, G, Ward, R

Refinement of the NHS locus on chromosome Xp22.13 and analysis of five candidate genes. by Toutain, A, Dessay, B, Ronce, N, Ferrante, M, Tranchemontagne, J, Newbury-Ecob, R, Wallgren-Pettersson, C, Burn, J, Kaplan, J, Rossi, A, Russo, S, Walpole, I, Hartsfield, J, Oyen, N, Nemeth, A, Bitoun, P, Trump, D, Moraine, C, Franco, B

Genetic variation in VEGF does not contribute significantly to the risk of congenital cardiovascular malformation. by Griffin, H, Hall, D, Topf, A, Eden, J, Stuart, A, Parsons, J, Peart, I, Deanfield, J, O'Sullivan, J, Babu-Narayan, S, Gatzoulis, M, Bu'lock, F, Bhattacharya, S, Bentham, J, Farrall, M, Granados Riveron, J, Brook, J, Burn, J, Cordell, H, Goodship, J, Keavney, B